Indeed, just the past 2 years of research identified GDF15, Lipocalin 2 (LCN2) and insulin-like 3 peptide (INSL3) as novel peripherally derived factors that activate CNS circuitry to drive cachexia symptoms (Figure 4). Here, INSL3 is linked to Cachexia.